Guest guest Posted April 15, 2011 Report Share Posted April 15, 2011 It depends upon the study. Some studies allow for other medications to be added, but others do not. They all allow for patients who are benefiting from the CAL-101 to remain on the CAL-101. Rick Furman, MD > > Will CAL-101 participants who receive the daily pill after > some study endpoint be allowed to pursue other forms of > concurrent treatment while they continue to rely on and > respond to CAL-101? > > Mark > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted April 15, 2011 Report Share Posted April 15, 2011 Is there a way to tell in advance which CAL studies will allow concurrent treatment after the study endpoint? For example, will the CAL combo studies allow such treatment? Mark Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.